SELENIUM AS A VERSATILE REAGENT IN ORGANIC SYNTHESIS: MORE THAN ALLYLIC OXIDATION

Synthesis of glucosamine-selenium compound and evaluation of its oral toxicity and in vitro anti-hepatitis B virus activity

Selenium supplements are beneficial to human health, however, concerns regarding the toxicity of inorganic selenium have stimulated research on safer organic compounds. The main objective of this study was to develop a novel glucosamine-selenium compound (Se-GlcN), clarify its structure, and subsequently investigate its oral toxicity and in vitro anti-hepatitis B virus (HBV) activity. Electron microscopy, infrared, ultraviolet spectroscopy, nuclear magnetic resonance and thermogravimetric analyses revealed a unique binding mode of Se-GlcN, with the introduction of the Se-O bond at the C6 position, resulting in the formation of two carboxyl groups. In acute toxicity studies, the median lethal dose (LD50) of Se-GlcN in ICR mice was 92.31 mg/kg body weight (BW), with a 95 % confidence interval of 81.88-104.07 mg/kg BW. A 30-day subchronic toxicity study showed that 46.16 mg/kg BW Se-GlcN caused livers and kidneys damage in mice, whereas doses of 9.23 mg/kg BW and lower were safe for the livers and kidneys. In vitro studies, Se-GlcN at 1.25 μg/mL exhibited good anti-HBV activity, significantly reducing HBsAg, HBeAg, 3.5 kb HBV RNA and total HBV RNA by 45 %, 54 %, 84 %, 87 %, respectively. In conclusion, the Se-GlcN synthesized in this study provides potential possibilities and theoretical references for its use as an organic selenium supplement.

Asymmetric Synthesis with Organoselenium Compounds - The Past Twelve Years

The discovery and synthetic applications of novel organoselenium compounds and their reactions proceeded rapidly during the past fifty years and such processes are now carried out routinely in many laboratories. At the same time, the growing demand for new enantioselective processes provided new challenges. The convergence of selenium chemistry and asymmetric synthesis led to key developments in the 1970s, although the majority of early work was based on stoichiometric processes. More recently, greater emphasis has been placed on greener catalytic variations, along with the discovery of novel reactions and a deeper understanding of their mechanisms. The present review covers the literature in this field from 2010 to early 2023 and encompasses asymmetric reactions mediated by chiral selenium-based reagents, auxiliaries, and especially, catalysts. Protocols based on achiral selenium compounds in conjunction with other species of chiral catalysts, as well as reactions that are controlled by chiral substrates, are also included.

Lighting Up the Organochalcogen Synthesis: A Concise Update of Recent Photocatalyzed Approaches

This review describes the recent advances in photocatalyzed reactions to form new carbon–sulfur and carbon–selenium bonds. With a total of 136 references, of which 81 articles are presented, the authors introduce in five sections an updated picture of the state of the art in the light-promoted synthesis of organochalcogen compounds (from 2019 to present). The light-promoted synthesis of sulfides by direct sulfenylation of C–C π-bonds; synthesis of sulfones; the activation of Csp2–N bond in the formation of Csp2–S bonds; synthesis of thiol ester, thioether and thioacetal; and the synthesis of organoselenium compounds are discussed, with detailed reaction conditions and selected examples for each protocol.

77Se and 13C NMR Characterization of Selenium Cyanides

Here, we describe a magnetic resonance spectroscopy characterization of selenium cyanide compounds, Se(CN)2, Se2(CN)2 and Se3(CN)2. Selenim-77 and carbon-13 nuclides were used to provide data of these species at room temperature. This is the first structural characterization performed using NMR for Se3(CN)2, while only low-temperature analyses have been conducted so far for Se(CN)2 and Se2(CN)2. Based on these limitations, a characterization study was deemed mandatory, especially from a synthetic chemistry point of view. In addition to these analyses, we carried out a purity assessment for Se3(CN)2 according to the melting point parameter along with a solubility evaluation.

ROS-Scavenging Selenofluoxetine Derivatives Inhibit In Vivo Serotonin Reuptake

While the neurochemistry that underpins the behavioral phenotypes of depression is the subject of many studies, oxidative stress caused by the inflammation comorbid with depression has not adequately been addressed. In this study, we described novel antidepressant-antioxidant agents consisting of selenium-modified fluoxetine derivatives to simultaneously target serotonin reuptake (antidepressant action) and oxidative stress. Excitingly, we show that one of these agents (1-F) carries the ability to inhibit serotonin reuptake in vivo in mice. We therefore present a frontier dual strategy that paves the way for the future of antidepressant therapies.